Why Jim Cramer Thinks META Can Be The Biggest Winner In A ‘Power Gating’ Scenario In a post on the X platform, Cramer stated that Investors are increasingly focused on “power gating,” a strategy that limits energy use and forces firms to prioritize efficiency over scale at any cost.
Could Buying the Vanguard Total Stock Market ETF in 2026 Make You a Millionaire? The magic of compounding can turn steady annual returns of 10% or less into life-changing wealth over the long term.
Steel Dynamics Jumps After Buyout Deal of BlueScope Metal With Australia’s SGH The proposal, submitted on December 12, valued BlueScope at A$30 a share, representing a near 27% premium to its December 11 close.
VTI vs. ITOT: How These Popular Total Stock Market ETFs Compare on Cost, Returns, and Diversification Explore how differences in fund size, holdings, and sector weightings set these two low-cost ETFs apart for investors seeking total stock market exposure.
Got $100,000? The 1 ETF I Would Buy Is VTI The Vanguard Total Stock Market ETF (VTI) has a place in almost every portfolio and is perhaps the ideal buy-and-hold ETF.
Looking for a Total Stock Market ETF? Here's How VTI and SCHB Stack Up for Investors With thousands more stocks and greater trading volume, VTI’s broader reach may influence how investors approach core U.S. equity exposure.
This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 No matter where the market is headed, this ETF can help protect your portfolio.
Tesla's Energy Business Might Be Its Saving Grace As EV Deliveries Drop Tesla deployed a record amount of energy storage in the fourth quarter, the company said on Friday.
SIDU Stock Is Already Up 390% In The Last Month – Why Is Retail Still Bullish? Sidus Space is enjoying its moment in the spotlight after winning a massive defense contract, and the growth witnessed by the space sector in recent months.
Outlook Therapeutics Tanks Over 60% On Another FDA Blow – Here’s How Retail Is Reacting The U.S. health regulatory agency, the FDA, rejected Outlook Therapeutics’ application for approval of its drug Lytenava, which is intended to treat wet AMD.
VTI vs. SPTM: How These Popular Total Stock Market ETFs Compare on Risk, Returns, and Cost Explore how differences in portfolio breadth and sector tilt could influence your choice between these two low-cost U.S. equity ETFs.
VTI vs. VTV: How Total Market Exposure Compares to Large-Cap Value Stocks Explore how differences in sector focus, risk, and yield between these Vanguard ETFs can shape your portfolio strategy.
Trump Media Partners With Crypto.com To Distribute Digital Tokens To Shareholders Trump Media & Technology said it plans to distribute a new digital token, with each shareholder likely to receive one token per DJT share.
A Low-Hype Software Stock More Than Doubled This Year: What’s Driving It — And Is There Upside Left? JFrog’s stock has outperformed most high-profile AI names, supported by a strong technical setup and the company’s improving growth profile.
Nvidia’s China Orders Are Surging – And Retail Believes Price Targets Will Follow According to a Reuters report, Chinese firms have lined up requests for more than 2 million H200 units slated for delivery in 2026, far more than the roughly 700,000 chips Nvidia currently has.
One Stop Systems Stock Rises After Hours On Selling Bressner To Focus On Higher-Growth Segments Hardware manufacturer OSS sold Bressner, which it acquired in October 2018, for $22.4 million to Hiper Euro GMBH on Tuesday.
Meta’s Strategic Move With Manus Could Mirror Instagram, WhatsApp Wins, Says Rosenblatt The firm noted that Manus’ agentic AI technology can enhance Meta’s offerings for small and medium-sized enterprises.
